Cargando…
Brainstem Modulates Parkinsonism-Induced Orofacial Sensorimotor Dysfunctions
Parkinson’s Disease (PD), treated with the dopamine precursor l-3,4-dihydroxyphenylalanine (L-DOPA), displays motor and non-motor orofacial manifestations. We investigated the pathophysiologic mechanisms of the lateral pterygoid muscles (LPMs) and the trigeminal system related to PD-induced orofacia...
Autores principales: | Nascimento, Glauce Crivelaro, Jacob, Gabrielle, Milan, Bruna Araujo, Leal-Luiz, Gabrielli, Malzone, Bruno Lima, Vivanco-Estela, Airam Nicole, Escobar-Espinal, Daniela, Dias, Fernando José, Del-Bel, Elaine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418831/ https://www.ncbi.nlm.nih.gov/pubmed/37569642 http://dx.doi.org/10.3390/ijms241512270 |
Ejemplares similares
-
Doxycycline attenuates l-DOPA-induced dyskinesia through an anti-inflammatory effect in a hemiparkinsonian mouse model
por: dos Santos Pereira, Maurício, et al.
Publicado: (2022) -
Common positioning errors in panoramic radiography: A review
por: Rondon, Rafael Henrique Nunes, et al.
Publicado: (2014) -
Brainstem and spinal cord MRI identifies altered sensorimotor pathways post-stroke
por: Karbasforoushan, Haleh, et al.
Publicado: (2019) -
Beneficial effects of benzodiazepine on masticatory muscle dysfunction induced by chronic stress and occlusal instability in an experimental animal study
por: Nascimento, Glauce C., et al.
Publicado: (2020) -
Corrigendum to “Herbal Mouthwash Containing Extracts of Baccharis dracunculifolia as Agent for the Control of Biofilm: Clinical Evaluation in Humans”
por: Pedrazzi, Vinícius, et al.
Publicado: (2016)